Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.

MLA

Bernardo, Bianca C., et al. “Therapeutic Silencing of MiR-652 Restores Heart Function and Attenuates Adverse Remodeling in a Setting of Established Pathological Hypertrophy.” FASEB Journal, vol. 28, no. 12, Dec. 2014, pp. 5097–110. EBSCOhost, https://doi.org/10.1096/fj.14-253856.

APA

Bernardo, B. C., Nguyen, S. S., Winbanks, C. E., Xiao-Ming Gao, Boey, E. J. H., Yow Keat Tham, Kiriazis, H., Ooi, J. Y. Y., Porrello, E. R., Igoor, S., Thomas, C. J., Gregorevic, P., Lin, R. C. Y., Xiao-Jun Du, & McMullen, J. R. (2014). Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. FASEB Journal, 28(12), 5097–5110. https://doi.org/10.1096/fj.14-253856

Chicago

Bernardo, Bianca C., Sally S. Nguyen, Catherine E. Winbanks, Xiao-Ming Gao, Esther J. H. Boey, Yow Keat Tham, Helen Kiriazis, et al. 2014. “Therapeutic Silencing of MiR-652 Restores Heart Function and Attenuates Adverse Remodeling in a Setting of Established Pathological Hypertrophy.” FASEB Journal 28 (12): 5097–5110. doi:10.1096/fj.14-253856.